SOURCE: Leerink Swann & Company

October 31, 2005 09:40 ET

Leerink Swann & Company Announces Appointment of Chris Kotowski as Director of Research

BOSTON, MA -- (MARKET WIRE) -- October 31, 2005 -- Leerink Swann & Company announces appointment of Chris Kotowski as Director of Research. "Leerink Swann has built a stellar reputation for independent fundamental equity research in the healthcare sector," said Jeffrey A. Leerink, CEO and Chairman of Leerink Swann. "As we continue to expand our abilities to serve our institutional clients, Chris Kotowski's extensive research management experience will contribute to that effort."

Chris Kotowski -- Director of Research

Chris Kotowski joins Leerink Swann as the Director of Research. Mr. Kotowski comes to Leerink Swann from CIBC World Markets where he spent a total of 18 years and 10 years managing its research effort. Prior to that, he was an Institutional Investor ranked analyst covering the banking industry. A graduate of California State University, Fullerton, Mr. Kotowski received an MBA from Columbia University.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information